Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT07185321
PHASE1

A Phase 1 Study of Mosliciguat in Healthy, Adult Males

Sponsor: Pulmovant, Inc.

View on ClinicalTrials.gov

Summary

This is a single-center, Phase 1, open-label, 3-period, fixed-sequence study to investigate the bioavailability, absorption, metabolism, excretion and the safety of mosliciguat administered to healthy male adults.

Official title: An Open-Label, Phase 1 Study to Investigate the Absolute Bioavailability and the Absorption, Metabolism, and Excretion of [14C]-Mosliciguat in Healthy, Adult Males

Key Details

Gender

MALE

Age Range

18 Years - 50 Years

Study Type

INTERVENTIONAL

Enrollment

8

Start Date

2025-06-10

Completion Date

2026-05

Last Updated

2025-09-22

Healthy Volunteers

Yes

Interventions

DRUG

Mosliciguat

Dose level for inhalation

DRUG

14C mosliciguat

Dose level

DEVICE

Dry Powder Inhaler

Dry powder inhaler for mosliciguat

Locations (1)

Pharmaron

Baltimore, Maryland, United States